Literature DB >> 28392847

The role of CRKL in breast cancer metastasis: insights from systems biology.

Abderrahim Chafik1.   

Abstract

Breast cancer metastasis is a complex and still weakly understood process that involves diverse cellular pathways. It accounts for the majority of deaths from breast cancer. Recently, microRNAs (miRNAs), small non-coding RNAs that regulate gene expression post-transcriptionally, have been shown to be involved in breast cancer metastasis. In particular, in a recent work it has been found that miR-429 may have a role in the inhibition of migration and invasion of breast cancer cells. Its target gene CRKL has been identified as a potential candidate. In this paper, by using systems biology tools we have shown that CRKL is involved in positive regulation of ERK1/2 signaling pathway and contribute to the regulation of LYN through a topological generalization of feed forward loop.

Entities:  

Keywords:  Breast cancer; CRKL; Metastasis; MicroRNA

Year:  2015        PMID: 28392847      PMCID: PMC5383793          DOI: 10.1007/s11693-015-9180-z

Source DB:  PubMed          Journal:  Syst Synth Biol        ISSN: 1872-5325


  22 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  miR-29b regulates migration of human breast cancer cells.

Authors:  Chen Wang; Zhen Bian; Da Wei; Jian-guo Zhang
Journal:  Mol Cell Biochem       Date:  2011-02-26       Impact factor: 3.396

Review 3.  Breast cancer metastasis.

Authors:  Olivia Jane Scully; Boon-Huat Bay; George Yip; Yingnan Yu
Journal:  Cancer Genomics Proteomics       Date:  2012 Sep-Oct       Impact factor: 4.069

4.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.

Authors:  Manav Korpal; Esther S Lee; Guohong Hu; Yibin Kang
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

6.  miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.

Authors:  Lin-Zi Li; Chris Zhiyi Zhang; Li-Li Liu; Chun Yi; Shi-Xun Lu; Xuan Zhou; Zhao-Jie Zhang; Yi-Han Peng; Yuan-Zhong Yang; Jing-Ping Yun
Journal:  Carcinogenesis       Date:  2013-10-01       Impact factor: 4.944

7.  Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.

Authors:  Hui Guan; Zhichao Zhou; Gary E Gallick; Shu-Fang Jia; Jaime Morales; Anil K Sood; Seth J Corey; Eugenie S Kleinerman
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

8.  Functions of the Lyn tyrosine kinase in health and disease.

Authors:  Evan Ingley
Journal:  Cell Commun Signal       Date:  2012-07-17       Impact factor: 5.712

Review 9.  MicroRNA: implications for cancer.

Authors:  Stefanie Sassen; Eric A Miska; Carlos Caldas
Journal:  Virchows Arch       Date:  2007-11-27       Impact factor: 4.064

Review 10.  Functional Role of the microRNA-200 Family in Breast Morphogenesis and Neoplasia.

Authors:  Bylgja Hilmarsdottir; Eirikur Briem; Jon Thor Bergthorsson; Magnus Karl Magnusson; Thorarinn Gudjonsson
Journal:  Genes (Basel)       Date:  2014-09-11       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.